Please login to the form below

Not currently logged in


This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca's Enhertu receives FDA grant for priority review

AstraZeneca's Enhertu receives FDA grant for priority review

AstraZeneca and Daiichi Sankyo’s jointly developed drug, Enhertu (trastuzumab deruxtecan), has received a notification of acceptance of the supplemental Biologics License Application (sBLA), alongside a grant for priority review.

Latest news

More from news
Approximately 22 fully matching, plus 620 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 90 partially matching documents found.

Latest appointments

More from appointments
Approximately 8 fully matching, plus 48 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 40 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....